Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 19

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 19
---
 Bylaws” refers to the Amended and Restated Bylaws of TuHURA; |

| • |     | “TuHURA Charter” refers to the Articles of Incorporation of TuHURA, as amended; |

| • |     | “TuHURA Common Stock” refers to the common stock, $0.001 par value per share, of TuHURA; |

| • |     | “TuHURA Material Adverse Effect” refers to any event, change, circumstance, occurrence or effect                                                                            
 that would prevent or delay beyond the End Date the performance by TuHURA or Merger Subs of its obligations under the Merger Agreement necessary to consummate the Mergers; |

| • |     | “TuHURA Share Issuance” refers to the issuance of shares of TuHURA Common Stock constituting the 
 Initial Share Consideration and the Kineta Delayed Share Consideration;                          |

| • |     | “TuHURA Share Value” refers to $5.7528 per share of TuHURA Common Stock; |

| • |     | “TuHURA Stockholder Approval” refers to with respect to the Authorized Shares Increase, the                                                                                                                                                              
 affirmative vote of the holders of a majority of the voting power of the shares of TuHURA Common Stock and, if necessary to comply with applicable law, with respect to the TuHURA Share Issuance, by the affirmative vote of the majority of votes cast 
 by the holders of shares of TuHURA Common Stock present in person or by proxy at the TuHURA special meeting;                                                                                                                                             |

| • |     | “Unpaid Company Transaction Expenses” refers to the aggregate amount (without duplication) of                                                                                                                                                          
 all costs, fees and expenses incurred by the Company or any of its subsidiaries, or for which the Company or any of its subsidiaries are or may become liable in connection with the transactions contemplated by the Merger Agreement and the         
 negotiation, preparation and execution of the Merger Agreement or any other agreement, document, instrument, filing, certificate, schedule, exhibit, letter or other document prepared or executed in connection with the transactions contemplated by 
 the Merger Agreement, including (i) the fees and disbursements payable by the Company to those persons identified in the representation of the Company relating to brokers; (ii) the fees and disbursements payable to legal counsel or                
 accountants, the maximum amount of fees and expenses payable to financial advisors, investment bankers, brokers, consultants, tax advisors,